These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25585248)

  • 21. FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.
    Adhikary S; Choudhary D; Tripathi AK; Karvande A; Ahmad N; Kothari P; Trivedi R
    Life Sci; 2019 Jul; 229():261-276. PubMed ID: 31082400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice.
    Lane NE; Yao W; Balooch M; Nalla RK; Balooch G; Habelitz S; Kinney JH; Bonewald LF
    J Bone Miner Res; 2006 Mar; 21(3):466-76. PubMed ID: 16491295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone.
    Piemontese M; Onal M; Xiong J; Wang Y; Almeida M; Thostenson JD; Weinstein RS; Manolagas SC; O'Brien CA
    Bone; 2015 Jun; 75():18-26. PubMed ID: 25700544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yeast-incorporated gallium attenuates glucocorticoid-induced bone loss in rats by inhibition of bone resorption.
    Ren Z; Yang L; Xue F; Meng Q; Wang K; Wu X; Ji C; Jiang T; Liu D; Zhou L; Zhang J; Fu Q
    Biol Trace Elem Res; 2013 Jun; 152(3):396-402. PubMed ID: 23532566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. β‑Ecdysterone promotes autophagy and inhibits apoptosis in osteoporotic rats.
    Tang YH; Yue ZS; Xin DW; Zeng LR; Xiong ZF; Hu ZQ; Xu CD
    Mol Med Rep; 2018 Jan; 17(1):1591-1598. PubMed ID: 29138818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
    Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
    J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-receptorial regulation of steroid hormones in bone cells: insights on glucocorticoid-induced osteoporosis.
    Pierotti S; Gandini L; Lenzi A; Isidori AM
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):292-9. PubMed ID: 17950597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid aggravates bone micro-architecture deterioration and skeletal muscle atrophy in mice fed on high-fat diet.
    Adhikary S; Kothari P; Choudhary D; Tripathi AK; Trivedi R
    Steroids; 2019 Sep; 149():108416. PubMed ID: 31150681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization.
    Yao W; Cheng Z; Pham A; Busse C; Zimmermann EA; Ritchie RO; Lane NE
    Arthritis Rheum; 2008 Nov; 58(11):3485-97. PubMed ID: 18975341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects.
    Alesci S; De Martino MU; Ilias I; Gold PW; Chrousos GP
    Neuroimmunomodulation; 2005; 12(1):1-19. PubMed ID: 15756049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone Marrow Stress Decreases Osteogenic Progenitors.
    Ng AH; Baht GS; Alman BA; Grynpas MD
    Calcif Tissue Int; 2015 Nov; 97(5):476-86. PubMed ID: 26220824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated mice.
    Yao W; Cheng Z; Busse C; Pham A; Nakamura MC; Lane NE
    Arthritis Rheum; 2008 Jun; 58(6):1674-86. PubMed ID: 18512788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoblastic Wnts differentially regulate bone remodeling and the maintenance of bone marrow mesenchymal stem cells.
    Wan Y; Lu C; Cao J; Zhou R; Yao Y; Yu J; Zhang L; Zhao H; Li H; Zhao J; Zhu X; He L; Liu Y; Yao Z; Yang X; Guo X
    Bone; 2013 Jul; 55(1):258-67. PubMed ID: 23334081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.
    Ding M; Cheng L; Bollen P; Schwarz P; Overgaard S
    Spine (Phila Pa 1976); 2010 Feb; 35(4):363-70. PubMed ID: 20110841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoids reduce alveolar and trabecular bone in mice.
    Bouvard B; Gallois Y; Legrand E; Audran M; Chappard D
    Joint Bone Spine; 2013 Jan; 80(1):77-81. PubMed ID: 22366143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of β‑ecdysterone on glucocorticoid‑induced apoptosis and autophagy in osteoblasts.
    Tang YH; Yue ZS; Li GS; Zeng LR; Xin DW; Hu ZQ; Xu CD
    Mol Med Rep; 2018 Jan; 17(1):158-164. PubMed ID: 29115419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Functional mechanism of glucocorticoid in bone turnover and bone structure].
    Ikeda S; Akahoshi S; Sakai A; Nakamura T
    Clin Calcium; 2006 Nov; 16(11):1805-11. PubMed ID: 17079846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.